Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.59 |
| ▸ | DRD1 | P21728 | 3/20 | 0.56 |
| ▸ | DRD2 | P14416 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.55 |
| ▸ | DRD5 | P21918 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | NAT1 | P18440 | 1/20 | 0.45 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.42 |
| ▸ | ABAT | P80404 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL27896687 | 0.98 | ALDH1A1 (0.56) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL1666926 | 0.95 | DRD1 (0.60) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL29733609 | 0.93 | DRD1 (0.58) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL29733602 | 0.93 | DRD1 (0.58) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL6032 | 0.87 | ALDH1A1 (0.68) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| Benzene SCHEMBL28288569 | 0.87 | ALDH1A1 (0.68) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL5733969 | 0.87 | ALDH1A1 (0.68) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL10969109 | 0.87 | ALDH1A1 (0.68) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL5490742 | 0.87 | ALDH1A1 (0.50) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL29671482 | 0.87 | ALDH1A1 (0.50) | ALDH1A1CYP2A6DRD1DRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117164628-A | Mercury ion ratio fluorescent probe based on hemicyanine and preparation and application thereof | 贺州学院 | 2023-12-05 | — | — | CN | claimed |
| CN-122051301-A | Preparation method and application of homogeneous vanadium battery conducting film modified in situ by covalent organic framework | 浙江工业大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20250357474-A1 | SILICON NANOPARTICLE ELECTRODE COMPOSITIONS AND METHODS OF MAKING THE SAME | ALLIANCE SUSTAINABLE ENERGY (US) | 2025-11-20 | — | — | US | disclosed |
| CN-117164628-A | Mercury ion ratio fluorescent probe based on hemicyanine and preparation and application thereof | 贺州学院 | 2023-12-05 | — | — | CN | disclosed |
| CN-117164628-A | Mercury ion ratio fluorescent probe based on hemicyanine and preparation and application thereof | 贺州学院 | 2023-12-05 | — | — | CN | disclosed |
| CN-116093283-A | Phthalocyanine-based covalent organic framework coated nano silicon composite material and preparation method thereof | 宜春江理锂电新能源产业研究院 | 2023-05-09 | — | — | CN | disclosed |
| US-11459242-B2 | Stabilized electrodes for ion batteries and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2022-10-04 | — | — | US | disclosed |
| CN-112156758-B | Porous material and preparation method and application thereof | 清华大学 | 2021-08-31 | — | — | CN | disclosed |
| CN-112156758-A | Porous material and preparation method and application thereof | 清华大学 | 2021-01-01 | — | — | CN | disclosed |
| US-10626095-B2 | Cyanotriazole compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-04-21 | — | — | US | disclosed |
| US-20160229816-A1 | CYANOTRIAZOLE COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2016-08-11 | — | — | US | disclosed |
| WO-2015008872-A1 | CYANOTRIAZOLE COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2015-01-22 | — | — | WO | disclosed |
| US-8513220-B2 | Aromatic compounds having sphingosine-1-phosphonate (S1P) receptor activity | ALLERGAN, INC. (US) | 2013-08-20 | — | — | US | disclosed |
| EP-2569322-A1 | AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY | Allergan, Inc. (US) | 2013-03-20 | — | — | EP | disclosed |
| US-20130018019-A1 | AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY | ALLERGAN, INC. (US) | 2013-01-17 | — | — | US | disclosed |
| WO-2011143332-A1 | AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY | ALLERGAN, INC. (US) | 2011-11-17 | — | — | WO | disclosed |
| US-20110281822-A1 | AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY | ALLERGAN, INC. (US) | 2011-11-17 | — | — | US | disclosed |
| EP-1575964-B1 | N-(BENZYL)AMINOALKYL CARBOXYLATE, PHOSPHINATES, PHOSPHONATES AND TETRAZOLES AS EDG RECEPTOR AGONISTS | MERCK & CO INC (US) | 2009-11-11 | — | — | EP | disclosed |
| US-7351725-B2 | N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists | MERCK & CO., INC. (US) | 2008-04-01 | — | — | US | disclosed |
| US-7351725-B2 | N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists | MERCK & CO., INC. (US) | 2008-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10626095-B2 | Cyanotriazole compounds | CS, PC, ACAT1 | ALDH1A1 1611/4885CYP2A6 3084/4885DRD1 4556/4885 |
| US-20130018019-A1 | AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY | S1PR1, S1PR3, S1PR2 | ALDH1A1 2617/4885CYP2A6 3025/4885DRD1 3624/4885 |
| US-20110281822-A1 | AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY | S1PR1, S1PR3, S1PR2 | ALDH1A1 2617/4885CYP2A6 3025/4885DRD1 3624/4885 |
| US-20160229816-A1 | CYANOTRIAZOLE COMPOUNDS | CS, PC, ACAT1 | ALDH1A1 1611/4885CYP2A6 3084/4885DRD1 4556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.